• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Warning for lopinavir/ritonavir oral solution

Article

The US Food and Drug Administration has notified health care practitioners that severe, possibly fatal, health problems have been reported in babies who have received lopinavir/ritonavir oral solution.

The US Food and Drug Administration (FDA) has notified health care practitioners that severe, possibly fatal, health problems have been reported in babies who have received lopinavir/ritonavir oral solution.

Lopinavir/Ritonavir oral solution is an antiviral medication containing alcohol and propylene glycol that is used in combination with other antiretroviral drugs to treat human immunodeficiency virus (HIV-1) infection .

Preterm neonates have a decreased ability to eliminate propylene glycol, which could lead to adverse events including serious heart, kidney, and respiratory problems.

Related Videos
Image Credit: Marcibowers.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.